Urological Devices – Market Insights – Latin America

Despite the short-term challenges posed by the COVID-19 pandemic, the Latin American market for urological devices will grow slowly through 2031. This market will be driven by the introduction of technologically advanced products, declining ASPs supporting the adoption among budget constraint facilities, and increasing patient awareness and physician training. In addition to that, the market growth will be supported by the rising trend for minimally invasive procedures as these techniques will not only provide improved efficacy but also reduced postoperative pain and shorter recovery periods.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for urological devices in Latin America from 2019 through 2031.

The COVID-19 pandemic has negatively impacted the Latin American urological device market.

To what extent did the COVID-19 pandemic impact the Latin American urological device market?

How did the impact of the COVID-19 pandemic differ between segments?

How quickly is the market recovering?

Post-sale services and product support are increasingly important to Latin American customers when negotiating purchases of urological devices.

What factors are contributing to purchasers’ increased emphasis on post-sale services?

What other strategies are competitors using to set themselves apart in Latin America?

How has the entry of local competitors affected the competitive strategies of international companies in Latin America?

Minimally invasive procedure volume will grow over the forecast period.

What factors contribute to the increase in minimally invasive treatments?

How have minimally invasive treatment options changed the BPH device market?

Which market segments will see the greatest adoption of minimally invasive treatments?

UI devices segment represent a significant proportion of overall market revenues.

What factors impact the use of UI devices?

How will ASPs of UI devices change over the forecast period?

Table of contents

Urological Devices - Market Insights - Latin America

Aditya Singh

Aditya Singh is a senior analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in minimally invasive therapies and emerging technologies markets. Aditya Singh holds Bachelor’s and Master’s degrees in Biotechnology from Amity University, Noida.

Contact sales Login to access report

Back to all Medtech Insights reports